GeneDx Holdings Corp. financial data

Symbol
WGS, WGSWW on Nasdaq
Location
333 Ludlow Street, North Tower, 8 Th Floor, Stamford, CT
State of incorporation
DE
Fiscal year end
December 31
Former names
Sema4 Holdings Corp. (to 1/5/2023), CM Life Sciences, Inc. (to 7/21/2021)
Latest financial report
10-Q - Q3 2024 - Oct 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 272 % +30.1%
Quick Ratio 16.3 % +44.3%
Debt-to-equity 93.2 % +32.4%
Return On Equity -40.1 % +75.3%
Return On Assets -20.7 % +78.2%
Operating Margin -21.6 % +90.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.5M shares +6.13%
Common Stock, Shares, Outstanding 27.4M shares +6.02%
Entity Public Float 96M USD -56%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 27.1M shares +5.07%
Weighted Average Number of Shares Outstanding, Diluted 27.1M shares +5.07%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 267M USD +29.4%
Research and Development Expense 46.4M USD -34.1%
Selling and Marketing Expense 65.3M USD -12.6%
General and Administrative Expense 100M USD -33.2%
Operating Income (Loss) -57.7M USD +88%
Nonoperating Income (Expense) -26.6M USD -229%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -84.2M USD +81.7%
Income Tax Expense (Benefit) -730K USD -62.2%
Net Income (Loss) Attributable to Parent -83.5M USD +81.8%
Earnings Per Share, Basic -2.9 USD/shares +91.6%
Earnings Per Share, Diluted -2.9 USD/shares +91.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 57.9M USD -33.8%
Marketable Securities, Current 58.6M USD +118%
Cash, Cash Equivalents, and Short-term Investments 114M USD
Accounts Receivable, after Allowance for Credit Loss, Current 32.9M USD -12.6%
Inventory, Net 10.8M USD +15.2%
Other Assets, Current 12.6M USD +151%
Assets, Current 186M USD +8.26%
Property, Plant and Equipment, Net 32.5M USD -37%
Operating Lease, Right-of-Use Asset 24.9M USD -9.44%
Intangible Assets, Net (Excluding Goodwill) 162M USD -7.96%
Goodwill 181M USD
Other Assets, Noncurrent 4.34M USD -28.4%
Assets 409M USD -2.02%
Accounts Payable, Current 9.02M USD -41.3%
Accrued Liabilities, Current 11.1M USD -16.9%
Contract with Customer, Liability, Current 40K USD -91.5%
Liabilities, Current 77.3M USD +13.1%
Deferred Income Tax Liabilities, Net 1.05M USD -48.8%
Operating Lease, Liability, Noncurrent 44.4M USD -0.09%
Other Liabilities, Noncurrent 13.5M USD -40.2%
Liabilities 204M USD +25.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 918K USD
Retained Earnings (Accumulated Deficit) -1.36B USD -6.55%
Stockholders' Equity Attributable to Parent 205M USD -19.6%
Liabilities and Equity 409M USD -2.02%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.4M USD +70.5%
Net Cash Provided by (Used in) Financing Activities -438K USD -100%
Net Cash Provided by (Used in) Investing Activities 843K USD
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 27.4M shares +6.02%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -16M USD -121%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 58.9M USD -33.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.02M USD +246%
Deferred Tax Assets, Valuation Allowance 272M USD +19.8%
Deferred Tax Assets, Gross 326M USD +16.2%
Operating Lease, Liability 46.8M USD -0.25%
Payments to Acquire Property, Plant, and Equipment 443K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -82.6M USD +82%
Lessee, Operating Lease, Liability, to be Paid 66.8M USD -16.6%
Property, Plant and Equipment, Gross 78.9M USD -48.4%
Operating Lease, Liability, Current 2.33M USD -3.24%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.21M USD +12.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.39M USD -4.55%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure -14.5%
Deferred Income Tax Expense (Benefit) -48.6M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 20M USD -39.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.3M USD +5.78%
Deferred Tax Assets, Operating Loss Carryforwards 258M USD +29.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 718K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.27M USD +2.67%
Operating Lease, Payments 346K USD -72%
Additional Paid in Capital 1.56B USD +2.15%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 8.45M USD -82.3%
Deferred Tax Assets, Net of Valuation Allowance 54.9M USD +1.1%
Share-based Payment Arrangement, Expense 5.38M USD +433%
Interest Expense 3M USD +0.47%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%